Health & Fitness
Health and Fitness
Health and Fitness
Tue, March 6, 2012
Mon, March 5, 2012
PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March... -- ANNAPOLIS, Md., March 5, 2012 /PRNewswire/ --
PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
ANNAPOLIS, Md., March 5, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: [ PIP ]), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that management will present at the ROTH 24th Annual OC Growth Stock Conference on Monday, March 12, 2012 at 5:30 pm PT at the Ritz-Carlton Laguna Niguel in Dana Point, CA.
Event: | 24th Annual ROTH Conference |
Date: | Monday, March 12, 2012 at 5:30 pm |
Place: | Ritz-Carlton Laguna Niguel, Salon 1 |
Time: | 5:30 pm PT |
About PharmAthene, Inc.
PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:
- SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine
- Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
- Recombinant BChE - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents
In addition, pursuant to an opinion issued September 22, 2011 from the Delaware Court of Chancery, PharmAthene is entitled to 50% of the profits over 10 years from all sales of SIGA Technologies' ST-246, and related products, a novel smallpox antiviral agent being developed by SIGA for the treatment and prevention of morbidity and mortality associated with exposure to the causative agent of smallpox (once SIGA receives the first $40 million in net profits from sales of ST-246.) For more information about PharmAthene, please visit [ www.PharmAthene.com ].
SOURCE PharmAthene, Inc.
[ Back to top ] RELATED LINKS
[ http://www.pharmathene.com ]
